Doctors scrutinize early COVID drug use: who did it help?
NCT ID NCT04365725
Summary
This study looked back at medical records to learn from the early, emergency use of the drug remdesivir in hospitalized COVID-19 patients. Researchers analyzed data from 84 adults across France who received the drug outside of formal trials. The goal was to understand which types of patients might benefit most from the treatment and to assess its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.